X;7 Translocation at p21.1 and q31.31 Disrupting DMD : A Multiomics Study of a Male Dystrophinopathy Case
Human Mutation · 2026
DOI: 10.1155/humu/8404135 ↗Kurz gefasst
Fallbericht in der Zeitschrift Human Mutation, 2026. Verfasst von Rui Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Research Institute Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital) Jinan Shandong Province China. Hauptthemen laut MEDLINE: Chromosomes, Human, X, Dystrophin, Muscular Dystrophy, Duchenne, Translocation, Genetic. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dystrophinopathy comprises a group of X‐linked recessive muscular disorders that primarily affect skeletal and/or cardiac muscles. Although more than 90% of dystrophinopathy patients exhibit detectable variants in the DMD gene, a small proportion of cases remain undiagnosed at the molecular level.
Methods
We employed an integrated multiomics approach, including RNA sequencing (RNA‐seq) of muscle tissue, optical genome mapping (OGM), short‐ and long‐read whole‐genome sequencing (WGS), and karyotype analysis to elucidate the genetic mechanism in a dystrophinopathy family.
Results
Integrated genomic analyses identified a balanced reciprocal translocation between Xp21.1 and 7q31.31 in the proband, with the X‐chromosomal breakpoint disrupting intron 20 of DMD . RNA sequencing of muscle tissue revealed severely reduced DMD transcript coverage downstream of the breakpoint, consistent with transcriptional interruption. Muscle immunohistochemistry showed absent dystrophin staining at the N‐terminus, rod domain, and C‐terminus, confirming loss of protein expression. The translocation was maternally inherited; the mother is a carrier with a dystrophinopathy phenotype.
Conclusions
We report a rare male case of dystrophinopathy caused by an X;autosome translocation disrupting DMD , thereby expanding the mutational spectrum of this disorder. Our findings underscore the value of comprehensive genomic profiling in resolving diagnostically elusive dystrophinopathy cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatric Research Institute Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital) Jinan Shandong Province China.
- Shandong Provincial Clinical Research Center for Children's Health and Disease Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital) Jinan Shandong Province China.
- Department of Neurology Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital) Jinan Shandong Province China.
- Department of Pathology Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital) Jinan Shandong Province China.
- Department of General Surgery Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital) Jinan Shandong Province China.
ORCID-Profile: Rui Dong, Hong Qin, Kaihui Zhang, Guohua Liu
Zitieren
APA
Dong, R., Ma, K., Bai, Y., Wang, X., Gao, M., Qin, H., Zhang, K., & Liu, G. (2026). X;7 Translocation at p21.1 and q31.31 Disrupting DMD : A Multiomics Study of a Male Dystrophinopathy Case. Human Mutation. https://doi.org/10.1155/humu/8404135
Vancouver
Dong R, Ma K, Bai Y, Wang X, Gao M, Qin H, et al. X;7 Translocation at p21.1 and q31.31 Disrupting DMD : A Multiomics Study of a Male Dystrophinopathy Case. Human Mutation. 2026. doi:10.1155/humu/8404135
BibTeX
@article{Dong2026,
author = {Dong, Rui and Ma, Kai and Bai, Yuexia and Wang, Xiaochen and Gao, Min and Qin, Hong and Zhang, Kaihui and Liu, Guohua},
title = {X;7 Translocation at p21.1 and q31.31 Disrupting DMD : A Multiomics Study of a Male Dystrophinopathy Case},
journal = {Human Mutation},
year = {2026},
doi = {10.1155/humu/8404135}
}
EUVIMED